TREVOR DOLLING: Open Payments
NPI 1457133738 · MANTECA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,696 in 159 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $2,256 · 2025 $4,696
Food & beverage: $4,414Education: $282
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $727 |
| Incyte Corporation | 30 | $704 |
| GENZYME CORPORATION | 11 | $614 |
| Janssen Biotech, Inc. | 12 | $613 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $379 |
| Regeneron Healthcare Solutions, Inc. | 15 | $361 |
| Arcutis Biotherapeutics, Inc. | 7 | $287 |
| E.R. Squibb & Sons, L.L.C. | 9 | $248 |
| Galderma Laboratories, L.P. | 11 | $233 |
| UCB, Inc. | 14 | $184 |
Products named: DUPIXENT, OPZELURA, TREMFYA, SKYRIZI, RINVOQ, Zoryve, Sotyktu, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
